The Global Emphysema Market is a critical and rapidly evolving segment of the broader Chronic Obstructive Pulmonary Disease (COPD) industry. Characterized by the progressive destruction of the alveoli (air sacs) in the lungs, emphysema leads to severe shortness of breath and a significant decline in quality of life. As of late 2025, the market is shifting from a purely symptomatic management...